Alteration of plasma metabolic profile and physical performance combined with metabolites is more sensitive to early screening for mild cognitive impairment

OBJECTIVE: Unbiased metabolic profiling has been initiated to identify novel metabolites. However, it remains a challenge to define reliable biomarkers for rapid and accurate diagnosis of mild cognitive impairment (MCI). Our study aimed to evaluate the association of serum metabolites with MCI, atte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yinjiao, Song, Peiyu, Zhang, Hui, Chen, Xiaoyu, Han, Peipei, Yu, Xing, Fang, Chenghu, Xie, Fandi, Guo, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360416/
https://www.ncbi.nlm.nih.gov/pubmed/35959293
http://dx.doi.org/10.3389/fnagi.2022.951146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360416/
https://www.ncbi.nlm.nih.gov/pubmed/35959293
http://dx.doi.org/10.3389/fnagi.2022.951146

Ejemplares similares